Pedometer Activity Monitoring After ASCT

Clinical trial NCT03238599 · COMPLETED

Trial details

NCT number: NCT03238599
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma Myeloma High-dose Chemotherapy Autologous Stem Cell Transplantation

Start date: 2017-11-02
Primary completion: 2022-02-15
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.